Nader Sanai
Clinical trials sponsored by Nader Sanai, explained in plain language.
-
New hope for aggressive brain tumor patients in clinical trial
Disease control Recruiting nowThis study is testing whether a pill called abemaciclib can help control an aggressive type of brain tumor called grade 3 meningioma. The drug is already approved for other cancers but not for brain tumors. Researchers will compare the pill against a placebo in 72 adults who have…
Phase: PHASE2 • Sponsor: Nader Sanai • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New weapon tested against deadly brain cancers
Disease control Recruiting nowThis early-stage trial is testing a new targeted drug called risvutatug rezetecan in people with aggressive, recurrent brain cancers. It aims to see how much of the drug reaches the brain tumor and to check its safety. The study will enroll about 15 people with either recurrent g…
Phase: EARLY_PHASE1 • Sponsor: Nader Sanai • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC